Bak E, et al. Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes. Int J Obes. 2010;34(2):250–60.
Barrero MJ, Boué S, Belmonte JCI. Epigenetic mechanisms that regulate cell identity. Cell Stem Cell. 2010;7(5):565–70.
CAS PubMed Article Google Scholar
Bhatia K, Das A. Combinatorial drug therapy in cancer-new insights. Life Sciences. 2020;118134.
Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. 2020;21(9):3233.
CAS PubMed Central Article Google Scholar
Burotto M, et al. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446–56.
CAS PubMed Article Google Scholar
Cai Q, et al. Toxicity of Evodiae fructus on rat liver mitochondria: the role of oxidative stress and mitochondrial permeability transition. Molecules. 2014;19(12):21168–82.
PubMed PubMed Central Article Google Scholar
Chan AL-F, et al. Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules. 2009;14(4):1342–52.
CAS PubMed PubMed Central Article Google Scholar
Chandarlapaty S. Negative feedback and adaptive resistance to the targeted therapy of cancer. Cancer Discov. 2012;2(4):311–9.
CAS PubMed PubMed Central Article Google Scholar
Chang W-L, et al. Tubulin-binding agents down-regulate matrix metalloproteinase-2 and-9 in human hormone-refractory prostate cancer cells–a critical role of cdk1 in mitotic entry. Biochem Pharmacol. 2015;94(1):12–21.
CAS PubMed Article Google Scholar
Chen MC, et al. Anti-proliferative effects of evodiamine on human thyroid cancer cell line ARO. J Cell Biochem. 2010;110(6):1495–503.
CAS PubMed Article Google Scholar
Chen T-C, et al. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells. Phytomedicine. 2016;23(1):68–78.
CAS PubMed Article Google Scholar
Cheng ZM, et al. Effects of evodiamine on invasion and polo-like kinase 1 expression of human gastric cancer cell [J]. J Jiangsu Univ (Medicine Edition) 2011;21:69–72.
Chien C-C, et al. Activation of JNK contributes to evodiamine-induced apoptosis and G 2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine. PLoS One. 2014;9(6):e99729.
PubMed PubMed Central Article Google Scholar
Chou S-T, et al. Exploration of anti-cancer effects and mechanisms of Zuo-Jin-Wan and its alkaloid components in vitro and in orthotopic HepG2 xenograft immunocompetent mice. BMC Complement Altern Med. 2017;17(1):121.
PubMed PubMed Central Article Google Scholar
Cohen SM, et al. Hepatotoxicity associated with the use of White Flood, a nutritional supplement. Pract Gastroenterol. 2012;36(10):45–7.
Dong G, et al. Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents. J Med Chem. 2010;53(21):7521–31.
CAS PubMed Article Google Scholar
Dong G, et al. New tricks for an old natural product: discovery of highly potent evodiamine derivatives as novel antitumor agents by systemic structure–activity relationship analysis and biological evaluations. 2012;55(17):7593–613.
Du J, et al. Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo. Oncol Rep. 2013;30(2):685–94.
CAS PubMed Article Google Scholar
Du J, et al. Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis. Anticancer Res. 2017;37(11):6141–51.
Duchartre Y, Kim Y-M, Kahn M. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol. 2016;99:141–9.
Ebi H. EGFR-Mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition. Ann Oncol. 2012;23:xi41.
Fang C, et al. Evodiamine induces G2/M arrest and apoptosis via mitochondrial and endoplasmic reticulum pathways in H446 and H1688 human small-cell lung cancer cells. PLoS One. 2014;9(12):e115204.
PubMed PubMed Central Article Google Scholar
Fang Q, et al. Evodiamine selectively inhibits multiple myeloma cell growth by triggering activation of intrinsic apoptosis pathway. Onco Targets Ther. 2019;12:11383.
CAS PubMed PubMed Central Article Google Scholar
Fendler A, et al. Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients. Nat Commun. 2020;11(1):1–16.
García-Gómez R, Bustelo XR, Crespo P. Protein–protein interactions: emerging oncotargets in the RAS-ERK pathway. Trends Cancer. 2018;4(9):616–33.
Gu Y, Mohammad IS, Liu Z. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncol Lett. 2020;19(4):2585–94.
CAS PubMed PubMed Central Google Scholar
Guan X, et al. Combined effects of berberine and evodiamine on colorectal cancer cells and cardiomyocytes in vitro. Eur J Pharmacol 2020;173031.
Guo X-X, et al. Evodiamine induces apoptosis in SMMC-7721 and HepG2 cells by suppressing NOD1 signal pathway. Int J Mol Sci. 2018;19(11):3419.
PubMed Central Article Google Scholar
Guo Q, et al. Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo. Onco Targets Ther. 2019;12:257.
CAS PubMed Article Google Scholar
Guo YJ, et al. ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997–2007.
PubMed PubMed Central Google Scholar
Gupta SC, et al. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta (BBA)-Gene Regul Mech. 2010;1799(10–12):775–87.
Han S, et al. Evodiamine selectively targets cancer stem-like cells through the p53–p21-Rb pathway. Biochem Biophys Res Commun. 2016;469(4):1153–8.
CAS PubMed Article Google Scholar
He C, Wan H. Drug metabolism and metabolite safety assessment in drug discovery and development. Expert Opin Drug Metab Toxicol. 2018;14(10):1071–85.
CAS PubMed Article Google Scholar
Heo SK, et al. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation. J Cell Biochem. 2009;107(1):123–33.
CAS PubMed Article Google Scholar
Hong Z, et al. Effects of evodiamine on PI3K/Akt and MAPK/ERK signaling pathways in pancreatic cancer cells. Int J Oncol. 2020;56(3):783–93.
CAS PubMed PubMed Central Google Scholar
Hu J, et al. Improved absorption and in vivo kinetic characteristics of nanoemulsions containing evodiamine–phospholipid nanocomplex. Int J Nanomed. 2014;9:4411.
Hu C, et al. Evodiamine sensitizes BGC-823 gastric cancer cells to radiotherapy in vitro and in vivo. Mol Med Rep. 2016;14(1):413–9.
CAS PubMed Article Google Scholar
Hu C-Y, et al. Evodiamine exerts an anti-hepatocellular carcinoma activity through a WWOX-dependent pathway. Molecules. 2017;22(7):1175.
PubMed Central Article Google Scholar
Hu X, et al. Antiproliferative effects of alkaloid evodiamine and its derivatives. Int J Mol Sci. 2018;19(11):3403.
PubMed Central Article Google Scholar
Huang Y-C, Guh J-H, Teng C-M. Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci. 2004;75(1):35–49.
CAS PubMed Article Google Scholar
Huang J, et al. Antiproliferation effect of evodiamine in human colon cancer cells is associated with IGF-1/HIF-1α downregulation. Oncol Rep. 2015;34(6):3203–11.
CAS PubMed Article Google Scholar
Huang C, et al. Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1. Oncol Rep. 2017;37(3):1637–45.
CAS PubMed Article Google Scholar
Hung P-H, et al. Inhibitory effect of evodiamine on aldosterone release by Zona glomerulosa cells in male rats. Chin J Physiol. 2001;44(2):53–8.
Hwang ST, et al. Evodiamine mitigates cellular growth and promotes apoptosis by targeting the c-met pathway in prostate cancer cells. Molecules. 2020;25(6):1320.
CAS PubMed Central Article Google Scholar
Hyun SY, et al. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70. Theranostics. 2021;11(6):2932.
CAS PubMed PubMed Central Article Google Scholar
Jia J, et al. Inhibition of human liver cancer cell growth by evodiamine involves apoptosis and deactivation of PI3K/AKT pathway. Appl Biol Chem. 2020;63(1):1–8.
留言 (0)